PKM and cancer: Indeed, CD44 expression has already been reported to not only to promote the metabolic shift of cancer cells via HIF-1 but also to induce glycolytic and antioxidant pathways via PKM2 in p53-mt/ hypoxic colorectal cell lines, leading to chemoresistance [26,28].